Healthcare Triangle, Inc.
HCTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.01 | -0.13 |
| FCF Yield | -4,753.52% | -2,226.79% | -354.27% | -14.63% |
| EV / EBITDA | 0.02 | 1.98 | 3.52 | -12.85 |
| Quality | ||||
| ROIC | -22.62% | -11.49% | -14.95% | 20.21% |
| Gross Margin | 17.71% | 13.88% | 8.88% | 11.69% |
| Cash Conversion Ratio | 1.03 | 1.93 | 3.27 | 0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | -29.82% | -34.18% | -36.77% | -36.60% |
| Free Cash Flow Growth | 18.16% | 41.73% | -585.20% | -213.43% |
| Safety | ||||
| Net Debt / EBITDA | 0.05 | 2.09 | 4.75 | -4.14 |
| Interest Coverage | -80.97 | -64.71 | -3.38 | -0.58 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 112.30 | 70.16 | 3.19 | -72.54 |